Related Experiment Videos
Drug-related cataract.
Optometry Clinics : the Official Publication of the Prentice Society
|January 1, 1991
Summary
Certain medications can cause lenticular changes, also known as drug-induced cataracts. This review details implicated drugs like corticosteroids and amiodarone, discussing their impact on lens opacities.
Area of Science:
- Ophthalmology
- Pharmacology
- Toxicology
Background:
- Drug-induced lenticular changes are a recognized clinical phenomenon.
- Several drug classes have been historically associated with the development of cataracts.
Purpose of the Study:
- To review and synthesize existing literature on drug-associated lenticular changes.
- To identify specific medications implicated in drug-induced cataracts.
- To discuss the characteristics, pathogenesis, and clinical observations of these drug-induced opacities.
Main Methods:
- Literature review of documented associations between drug therapy and lenticular changes.
- Analysis of clinical observations for implicated agents.
- Comparative discussion of drug-specific opacity locations and proposed pathogenic mechanisms.
Main Results:
- Corticosteroids, phenothiazines, miotics, gold compounds, amiodarone, and allopurinol are frequently implicated in drug-induced lenticular changes.
- Variations exist in the location of lens opacities depending on the specific drug agent.
- Potential pathogenic pathways contributing to drug-induced cataract formation are discussed.
Conclusions:
- A range of medications can induce significant lenticular changes, necessitating clinical awareness.
- Understanding the specific drug-opacity associations aids in diagnosis and management.
- Further research into the pathogenesis of drug-induced cataracts is warranted.